Cite
APA Citation
Wu, X., Xia, L., Zhou, Q., Zhu, J., Wang, K., Chen, J., Huang, Y., Kurb, G., Chang, B., Zhao, W., Wang, X., Yang, Y., Lin, Z., Luo, X., Lou, G., Wang, C., Wang, J., & Meng, H. (n.d.). 357 GLS-010 (Zimberelimab), a novel fully human anti-PD-1 mAb in chinese patients with recurrent/metastatic cervical cancer: results from a multicenter, open-label, single-arm phase II trial. International journal of gynecological cancer, 30, A147. http://access.bl.uk/ark:/81055/vdc_100144712509.0x00001e